The effect of dexmedetomidine, remifentanil and metoral in reducing patient bleeding during rhinoplasty surgery.

Q3 Medicine
Alireza Kamali, Narges Naseri, Farzad Zamani, Narges Anosheh, Siamak Rakei
{"title":"The effect of dexmedetomidine, remifentanil and metoral in reducing patient bleeding during rhinoplasty surgery.","authors":"Alireza Kamali, Narges Naseri, Farzad Zamani, Narges Anosheh, Siamak Rakei","doi":"10.5935/0946-5448.20230024","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Rhinoplasty is one of the most common surgeries in the ENT department. Rhinoplasty hemorrhage is one of the complications that different strategies have been used to reduce it. Reduction of bleeding reduces the risk of complications such as hemolytic and non-hemolytic reactions, acute lung damage, viral and bacterial infections, hypothermia and coagulation disorders. Therefore, the aim of this study was to compare the effect of dexmedetomidine, remifentanil and metoral in reducing patient bleeding during rhinoplasty surgery.</p><p><strong>Materials and methods: </strong>This randomized, double-blind trial was performed on rhinoplasty patients. Rhinoplasty candidates who had the inclusion and exclusion criteria were divided into three groups of remifentanil, metoral and dexmedetomidine according to the random number table. Then 0.5 mg/kg/h of dexmedetomidine in the first group was administered, followed by 100-150 kg/h remifentanil in the second group and 50 mg metoral in the third group. Mean blood pressure, heart rate, mean bleeding and surgeon satisfaction were recorded in designed form. Data were analyzed by Spss-22 software.</p><p><strong>Results: </strong>The mean blood pressure of patients in remifentanil group was lower than the other two groups (P = 0.03). In all three times during surgery, recovery and overall time, the amount of bleeding in the remifentanil group was found to be less than the other two groups. Furthermore, the rate of bleeding in the dexmedetomidine group was found to be less than the metoral group (P = 0.03, P = 0.02). The surgeon's satisfaction score in the remifentanil group was higher than the other two groups. Satisfaction score was higher in dexmedetomidine group than metoral group (P = 0.03). The recovery time in the metoral group was shorter than the other two groups (P = 0.02).</p><p><strong>Conclusion: </strong>Remifentanil caused a good and appropriate reduction of blood pressure in rhinoplasty surgery, causing less bleeding and higher satisfaction.</p>","PeriodicalId":39842,"journal":{"name":"International Tinnitus Journal","volume":"27 2","pages":"154-159"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Tinnitus Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/0946-5448.20230024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Rhinoplasty is one of the most common surgeries in the ENT department. Rhinoplasty hemorrhage is one of the complications that different strategies have been used to reduce it. Reduction of bleeding reduces the risk of complications such as hemolytic and non-hemolytic reactions, acute lung damage, viral and bacterial infections, hypothermia and coagulation disorders. Therefore, the aim of this study was to compare the effect of dexmedetomidine, remifentanil and metoral in reducing patient bleeding during rhinoplasty surgery.

Materials and methods: This randomized, double-blind trial was performed on rhinoplasty patients. Rhinoplasty candidates who had the inclusion and exclusion criteria were divided into three groups of remifentanil, metoral and dexmedetomidine according to the random number table. Then 0.5 mg/kg/h of dexmedetomidine in the first group was administered, followed by 100-150 kg/h remifentanil in the second group and 50 mg metoral in the third group. Mean blood pressure, heart rate, mean bleeding and surgeon satisfaction were recorded in designed form. Data were analyzed by Spss-22 software.

Results: The mean blood pressure of patients in remifentanil group was lower than the other two groups (P = 0.03). In all three times during surgery, recovery and overall time, the amount of bleeding in the remifentanil group was found to be less than the other two groups. Furthermore, the rate of bleeding in the dexmedetomidine group was found to be less than the metoral group (P = 0.03, P = 0.02). The surgeon's satisfaction score in the remifentanil group was higher than the other two groups. Satisfaction score was higher in dexmedetomidine group than metoral group (P = 0.03). The recovery time in the metoral group was shorter than the other two groups (P = 0.02).

Conclusion: Remifentanil caused a good and appropriate reduction of blood pressure in rhinoplasty surgery, causing less bleeding and higher satisfaction.

右美托咪定、瑞芬太尼和美托乐对减少鼻整形手术中患者出血的影响。
简介隆鼻手术是耳鼻喉科最常见的手术之一。隆鼻手术出血是并发症之一,人们采用了不同的策略来减少出血。减少出血可降低发生溶血和非溶血反应、急性肺损伤、病毒和细菌感染、低体温和凝血功能障碍等并发症的风险。因此,本研究旨在比较右美托咪定、瑞芬太尼和美托拉尔在减少鼻整形手术中患者出血量方面的效果:这项随机双盲试验是针对鼻整形手术患者进行的。根据随机数字表将符合纳入和排除标准的鼻整形手术患者分为瑞芬太尼、美托拉尔和右美托咪定三组。第一组使用 0.5 mg/kg/h 右美托咪定,第二组使用 100-150 kg/h 瑞芬太尼,第三组使用 50 mg 甲托咪定。用设计好的表格记录平均血压、心率、平均出血量和外科医生满意度。数据采用 Spss-22 软件进行分析:结果:瑞芬太尼组患者的平均血压低于其他两组(P = 0.03)。瑞芬太尼组患者在手术、术后恢复和整个手术期间的出血量均少于其他两组。此外,右美托咪定组的出血量也少于口服组(P = 0.03,P = 0.02)。瑞芬太尼组的外科医生满意度评分高于其他两组。右美托咪定组的满意度评分高于口服组(P = 0.03)。口服组的恢复时间短于其他两组(P = 0.02):结论:雷米芬太尼能在鼻整形手术中很好地适当降低血压,减少出血,提高满意度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Tinnitus Journal
International Tinnitus Journal Medicine-Otorhinolaryngology
CiteScore
0.70
自引率
0.00%
发文量
11
期刊介绍: The International Tinnitus Journal is the first peer review journal to provide a forum for exchange of information of on-going basic and clinical science efforts for understanding tinnitus and its application to patient diagnosis and treatment. Subject areas to be covered range from fundamental theory to clinical applications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信